Extending the platinum-free interval (PFI) with Trabectedin plus Pegylated liposomal doxorubicin (PLD) in a patient with partially platinum sensitive (PPS) recurrent ovarian cancer.

Authors
Publication date
1 January 2015
Publisher

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    Archivio della ricerca- Università di Roma La Sapienza

    redirect
    oaioai:iris.uniroma1.it:11573/853...
    Last time updated on 12/11/2016